<DOC>
	<DOCNO>NCT00650338</DOCNO>
	<brief_summary>To investigate dose-response relationship DE-104 ophthalmic solution lower intraocular pressure ( IOP ) subject Primary Open-Angle Glaucoma Ocular Hypertension</brief_summary>
	<brief_title>Safety Efficacy Study DE-104 Ophthalmic Solution Treat Open-angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Provided sign , write informed consent . Diagnosed primary openangle glaucoma ocular hypertension . 18 year age old . If subject female childbearing potential , must utilize reliable contraceptive throughout study , must negative urine pregnancy test prior enrollment study . Females pregnant , nurse planning pregnancy , females childbearing potential use reliable method contraception . Presence abnormality significant illness could expect interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>